No Data
No Data
GSK Wins EU Backing for RSV Vaccine for Those Aged 50 – 59
Express News | Agenus to Provide Second Quarter 2024 Financial Report and Corporate Update
Express News | Agenus Gains in Volume Surge, Last up 8.2%
Express News | Agenus Inc : Jefferies Raises Target Price to $7 From $3
Express News | Agenus Inc : Jefferies Cuts to Hold From Buy
Express News | Jefferies Downgrades Agenus to Hold, Raises Price Target to $7
No Data